Skip to main
NTGN
NTGN logo

Neon Therapeutics (NTGN)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Neon Therapeutics (NTGN) Stock

About Neon Therapeutics (NTGN)

BioNTech US, Inc. develops novel therapeutics leveraging neoantigen biology to treat cancer. It offers NEO-PV-01, a personalized neoantigen vaccine that builds upon initial clinical trials. The company was founded by James P. Allison, Edward J. Fritsch, Nir Hacohen, Eric S. Lander, Robert Schreiber, Ton Schumacher and Catherine Wu on October 21, 2013 and is headquartered in Cambridge, MA.
Market cap$88.93M
Today's volume
Revenue (TTM)
Avg. daily volume480.44K
EBITDA (TTM)
Open
Price / earnings ratio-1.14x
Today's range
Debt / equity
52 week range$0.88 - $5.97
5 year debt / equity5.56x
Beta (LTM)0.71x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsMay 1, 2020
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jul 09, 2025, the market cap for NTGN stock is $88.93M

The current P/E ratio for NTGN stock is -1.14

The 52-week high for NTGN stock is $5.97. The current NTGN stock price $undefined is 100.00% below its 52-week high

The 52-week low for NTGN stock is $0.88. The current NTGN stock price $undefined has increased 100.00% from its 52-week low

No, the NTGN stock does not pay dividends to its shareholders

How to buy NTGN stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in NTGN stock

    Navigate to the Explore page. Then, type NTGN into the search bar. When you see NTGN stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased NTGN stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Neon Therapeutics Stock Earnings

The value each NTGN share was expected to gain vs. the value that each NTGN share actually gained.

Neon Therapeutics (NTGN) reported Q4 2019 earnings per share (EPS) of -$0.63, missing estimates of -$0.62 by 1.61%. In the same quarter last year, Neon Therapeutics's earnings per share (EPS) was $0. Neon Therapeutics is expected to release next earnings on 05/01/2020, with an earnings per share (EPS) estimate of $0.

Buy Neon Therapeutics (NTGN) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.